Загрузка...
Response of rat model of Pneumocystis carinii pneumonia to continuous infusion of deferoxamine.
The iron-chelating drug deferoxamine mesylate (DFO) is active against Pneumocystis carinii in vitro and in rat and mouse models of P. carinii pneumonia. Because DFO has a short half-life, daily divided or continuous dosage was expected to improve the dose response, as is the case with DFO treatment...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
1995
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC162759/ https://ncbi.nlm.nih.gov/pubmed/7492082 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|